Last quarter (Q ), KemPharm's total revenue was $2.87M, an increase of 46.26% from the same quarter last year. In Q, KemPharm's net income was $-6.62M. See KemPharm’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ 10.72M	$ 28.65M	$ 13.29M	$ 12.84M	$ 0.00	$ 0.00
Cost of Revenue	$ 259.00K	$ 2.06M	$ 1.30M	$ 2.94M	$ 0.00	-
Gross Profit	$ 10.46M	$ 26.59M	$ 11.98M	$ 9.89M	$ 0.00	-
Operating Expense	$ 28.89M	$ 18.86M	$ 16.76M	$ 30.23M	$ 54.27M	$ 33.37M
Operating Income	$ -18.43M	$ 7.73M	$ -4.78M	$ -20.34M	$ -54.27M	$ -33.37M
Net Non Operating Interest Income Expense	$ -210.00K	$ -128.00K	$ -7.00M	$ -6.21M	$ -6.67M	$ -6.97M
Other Income Expense	$ -17.30M	$ -16.12M	$ -1.01M	$ 2.00M	$ 4.34M	$ -3.09M
Pretax Income	$ -35.94M	$ -8.52M	$ -12.79M	$ -24.54M	$ -56.59M	$ -43.43M
Tax Provision	$ -718.00K	$ 34.00K	$ -34.00K	$ -22.00K	$ -126.00K	$ -43.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -35.23M	$ -62.90M	$ -12.76M	$ -24.52M	$ -56.47M	$ -43.39M
Basic EPS	$ -0.89	$ -2.11	$ -3.21	$ -13.28	$ -50.40	$ -47.36
Diluted EPS	$ -0.89	$ -2.11	$ -3.21	$ -13.28	$ -50.40	$ -47.36
Basic Average Shares	$ 138.80M	$ 29.77M	$ 3.98M	$ 1.85M	$ 1.12M	$ 915.81K
Diluted Average Shares	$ 138.80M	$ 29.77M	$ 3.98M	$ 1.85M	$ 1.12M	$ 915.81K
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 29.15M	$ 20.92M	$ 18.07M	$ 33.18M	$ 54.27M	$ 33.37M
Net Income From Continuing And Discontinued Operation	$ -35.23M	$ -8.55M	$ -12.76M	$ -24.52M	$ -56.47M	$ -43.39M
Normalized Income	$ -18.41M	$ 3.21M	$ -11.75M	$ -26.52M	$ -60.80M	$ -40.30M
Interest Expense	$ 415.00K	$ 376.00K	$ 4.79M	$ 4.86M	$ 5.47M	$ 5.78M
EBIT	$ -35.53M	$ -8.14M	$ -8.01M	$ -19.69M	$ -51.12M	$ -37.65M
EBITDA	$ -34.82M	$ -7.89M	$ -7.74M	$ -19.38M	$ -50.80M	$ -37.32M

Currency in USD

KemPharm Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing